Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?

医学 肝硬化 肝细胞癌 免疫学 乙型肝炎病毒 肝病 乙型肝炎 肝癌 病毒性肝炎 肝炎 慢性感染 病毒学 病毒 免疫系统 内科学
作者
Andrea M. Woltman,André Boonstra,Harry L.A. Janssen
出处
期刊:Gut [BMJ]
卷期号:59 (01): 115-125 被引量:36
标识
DOI:10.1136/gut.2009.181040
摘要

Hepatitis viruses, of which the common types are A, B and C, are hepatotropic and primarily infect hepatocytes. Both hepatitis B virus (HBV) and hepatitis C virus (HCV) can cause chronic liver disease and may elicit progressive liver injury leading to increased risk of developing liver cirrhosis, liver failure and liver cancer.1 2 The outcome of infection, and the development of liver disease are determined by viral and host factors (fig 1). Figure 1 Hepatitis B virus (HBV) and hepatitis C virus (HCV) disease pathogenesis. (A) Following infection with HBV, there will be an initial acute hepatitis that could be symptomatic (nausea and icterus). Successful clearance and resolution of HBV infection (10–90%) depends on the route of infection, age and immune status of the individual, with most infections of immunocompetent adults being self-limiting. Most cases of chronic HBV infection are caused by vertical transmission from mother to neonate. If the infection is not controlled, continuing liver inflammation, tissue injury and aberrant repair result in chronic hepatitis, liver fibrosis and cirrhosis. Pro-oncogenic features of HBV itself in combination with ongoing inflammation and tissue injury result in an increased risk for the development of hepatocellular carcinoma (HCC). Persistent immune control over the HBV can be achieved in up to 20–30% of the patients after treatment with pegylated interferon α (PEG-IFNα), which has several side effects. Sustained response rates after nucleos(t)ide analogue treatment, which directly interferes with viral replication and probably has to be given life long, are even lower due to higher off-treatment relapses. In addition, breakthrough of resistant HBV variants limits long-term use. (B) Acute HCV infection is asymptomatic in most cases. HCV readily establishes chronic infection in otherwise immunocompetent adults (70–90% of HCV-infected individuals). If the infection is not controlled, continuing liver inflammation, tissue injury and aberrant repair result in …

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
失眠的蓝完成签到,获得积分10
1秒前
zkexuan发布了新的文献求助10
4秒前
CC完成签到,获得积分10
6秒前
dracovu完成签到,获得积分10
6秒前
一一完成签到,获得积分10
7秒前
8秒前
yulian完成签到,获得积分10
9秒前
斯文败类应助静好采纳,获得10
9秒前
sia完成签到 ,获得积分10
11秒前
彤快乐完成签到,获得积分10
12秒前
www完成签到,获得积分10
15秒前
蜜CC完成签到,获得积分10
16秒前
万默完成签到 ,获得积分10
17秒前
脑洞疼应助科研通管家采纳,获得10
18秒前
zhao应助科研通管家采纳,获得10
18秒前
Ganlou应助科研通管家采纳,获得20
18秒前
和平完成签到 ,获得积分10
18秒前
共享精神应助科研通管家采纳,获得10
18秒前
18秒前
zvk应助科研通管家采纳,获得10
18秒前
华子的五A替身完成签到,获得积分10
19秒前
zkexuan完成签到,获得积分10
19秒前
plain完成签到,获得积分10
20秒前
21秒前
二世小卒完成签到 ,获得积分10
21秒前
www完成签到 ,获得积分10
22秒前
1233333完成签到,获得积分10
22秒前
xiaozhejia完成签到,获得积分10
23秒前
静好完成签到,获得积分20
24秒前
24秒前
nieinei完成签到 ,获得积分10
25秒前
ppp完成签到,获得积分10
25秒前
静好发布了新的文献求助10
27秒前
kelaibing完成签到,获得积分10
29秒前
小鹿完成签到,获得积分20
36秒前
丰富猕猴桃完成签到,获得积分10
36秒前
狗儿吖完成签到,获得积分10
36秒前
落寞的嵩完成签到,获得积分10
37秒前
CNX完成签到,获得积分10
37秒前
高分求助中
Solution Manual for Strategic Compensation A Human Resource Management Approach 1200
Natural History of Mantodea 螳螂的自然史 1000
Glucuronolactone Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031 800
A Photographic Guide to Mantis of China 常见螳螂野外识别手册 800
Autoregulatory progressive resistance exercise: linear versus a velocity-based flexible model 500
The analysis and solution of partial differential equations 400
Sociocultural theory and the teaching of second languages 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3339197
求助须知:如何正确求助?哪些是违规求助? 2967110
关于积分的说明 8628328
捐赠科研通 2646630
什么是DOI,文献DOI怎么找? 1449297
科研通“疑难数据库(出版商)”最低求助积分说明 671343
邀请新用户注册赠送积分活动 660180